| 注册
首页|期刊导航|中国药房|上海市实施国家基本药物制度对各类药品企业的损益影响分析

上海市实施国家基本药物制度对各类药品企业的损益影响分析

李婉莹 罗力 邵月琴 沈宏 李强 陈海乐 周奕男 张崖冰 王晓栋 纽小庆

中国药房2013,Vol.24Issue(4):291-293,3.
中国药房2013,Vol.24Issue(4):291-293,3.DOI:10.6039/j.issn.1001-0408.2013.04.02

上海市实施国家基本药物制度对各类药品企业的损益影响分析

Analysis of the Profit and Loss of Pharmaceutical Enterprises Caused by National Essential Drug System in Shanghai City

李婉莹 1罗力 1邵月琴 2沈宏 2李强 2陈海乐 1周奕男 1张崖冰 3王晓栋 4纽小庆4

作者信息

  • 1. 复旦大学公共卫生学院/教育部公共卫生安全重点实验室,上海200032
  • 2. 上海市嘉定区初级卫生保健中心,上海201805
  • 3. 独立研究者,上海200000
  • 4. 上海市静安区老年医院,上海200040
  • 折叠

摘要

Abstract

OBJECTIVE: To evaluate the profit and loss of pharmaceutical enterprises after the implementation of national essential drug system in Shanghai. METHODS: The changes of prices, consumption amount and sum of medicines both in grass-root sales market and non-grass-root sales market were analyzed after the implementation of national essential drug system; the sales changes of different types of enterprises were compared. RESULTS & CONCLUSION: After the implementation of national essential drug system in Shanghai, the supply price of medicine which is weighted and standardized in the second half of 2011 has reduced by 6.03%. But actually the weighted supply price has increased by 1.41% because most of high price medicines are used in community health service center. Total consumption sum of grass-root sales market has increased by 3.72% when the declining of grass-root market's sales has been reversed. The national essential drug system benefit extra large enterprises; the changes of consumption sum in other enterprises which has large original market share have no related to its rank of sales amount; several enterprises with little original market share surge in consumption sum. The consumption sum of local pharmaceutical enterprises decrease by 16.97% , while that of non-local pharmaceutical enterprises increase by 9.50% which benefited more from national essential drug system.

关键词

基本药物/药品企业/损益分析/上海

Key words

Essential drugs/Pharmaceutical enterprise/Profit and loss analysis/Shanghai

分类

医药卫生

引用本文复制引用

李婉莹,罗力,邵月琴,沈宏,李强,陈海乐,周奕男,张崖冰,王晓栋,纽小庆..上海市实施国家基本药物制度对各类药品企业的损益影响分析[J].中国药房,2013,24(4):291-293,3.

基金项目

国家自然科学基金资助项目(No.71073027) (No.71073027)

"985工程"三期整体推进社会科学研究项目(No.2011SHKXZD020) (No.2011SHKXZD020)

教育部创新团队项目(No.IRT0912) (No.IRT0912)

教育部哲学社会科学研究重大课题攻关项目(No.07JZD0017) (No.07JZD0017)

2011-2012年度上海市卫生局卫生政策研究课题项目(No.2011HP005) (No.2011HP005)

中国药房

OACSCDCSTPCD

1001-0408

访问量0
|
下载量0
段落导航相关论文